Indoco Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2025 ,inter alia, to consider and approve 1. The Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended 31st March, 2025. 2. To recommend a final dividend, if any for the financial year ending 31st March, 2025.